These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 9596285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. New macrolides or new quinolones as monotherapy for patients with community-acquired pneumonia: our cup runneth over?
    Yu VL, Vergis EN.
    Chest; 1998 May; 113(5):1158-9. PubMed ID: 9596286
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
    Nakamura S, Yanagihara K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Senjyu H, Saito A, Kohno S.
    J Infect; 2009 Sep; 59(3):222-4. PubMed ID: 19592113
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Legionnaires' disease and pneumonia. Beware the temptation to underestimate this "exotic" cause of infection.
    Akbas E, Yu VL.
    Postgrad Med; 2001 May; 109(5):135-8, 141-2, 147. PubMed ID: 11381664
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents.
    Marrie TJ.
    Infect Dis Clin North Am; 2004 Dec; 18(4):829-41. PubMed ID: 15555827
    [Abstract] [Full Text] [Related]

  • 11. Empirical Therapy of Community-Acquired Pneumonia: Advancing Evidence or Just More Doubt?
    Mandell LA, Waterer GW.
    JAMA; 2015 Jul 28; 314(4):396-7. PubMed ID: 26219057
    [No Abstract] [Full Text] [Related]

  • 12. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.
    Mandell LA, Bartlett JG, Dowell SF, File TM, Musher DM, Whitney C, Infectious Diseases Society of America.
    Clin Infect Dis; 2003 Dec 01; 37(11):1405-33. PubMed ID: 14614663
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Coverage of atypical pathogens for hospitalised patients with community-acquired pneumonia is not guided by clinical parameters.
    Piso RJ, Arnold C, Bassetti S.
    Swiss Med Wkly; 2013 Dec 01; 143():w13870. PubMed ID: 24089030
    [Abstract] [Full Text] [Related]

  • 15. Legionellosis.
    Pedro-Botet ML, Sabrià M.
    Semin Respir Crit Care Med; 2005 Dec 01; 26(6):625-34. PubMed ID: 16388431
    [Abstract] [Full Text] [Related]

  • 16. Legionnaires disease and the updated IDSA guidelines for community-acquired pneumonia.
    Yu VL, Ramirez J, Roig J, Sabria M.
    Clin Infect Dis; 2004 Dec 01; 39(11):1734-7; author reply 1737-8. PubMed ID: 15578385
    [No Abstract] [Full Text] [Related]

  • 17. Persistently positive culture results in a patient with community-acquired pneumonia due to Legionella pneumophila.
    Tan JS, File TM, DiPersio JR, DiPersio LP, Hamor R, Saravolatz LD, Stout JE.
    Clin Infect Dis; 2001 Jun 01; 32(11):1562-6. PubMed ID: 11340527
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team.
    Mundy LM, Oldach D, Auwaerter PG, Gaydos CA, Moore RD, Bartlett JG, Quinn TC.
    Chest; 1998 May 01; 113(5):1201-6. PubMed ID: 9596295
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.